The company is headquartered in Alphen aan den Rijn, Netherlands
After spending $100 million on the drugs for weight loss in 2024 and seeing sizable operating losses to boot, Point32Health announced in May that it would stop automatically covering the drugs for obesity starting in 2026
trevogrumab, being developed in combination with semaglutide for muscle preservation during GLP-1-mediated weight loss
Did eating foods rich in prebiotic compounds improve mood in people with moderate psychological distress
For a closer look at titration and weekly dosing, read Semaglutide dosage for weight loss
Real-world data from tens of thousands of patients on extended GLP-1 therapy (13+ years) shows that side effects typically plateau after the first 36 months, and many patients report improved quality of life, reduced hunger-related stress, and better disease control if they have type 2 diabetes